Lambutrix (Lorazepam)

Lorazepam enhances the activity of the neurotransmitter GABA at the GABA‑A receptor, increasing chloride ion influx into neurons. This results in greater inhibitory signaling, producing calming, anticonvulsant, and sedative effects.

The appropriate dose of Lambutrix is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.

Lorazepam should be used during pregnancy only if the potential benefit outweighs the risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers, and alternatives should be considered when possible.

To request Lambutrix, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lambutrix (lorazepam) offers a relatively rapid onset of action and a moderate duration compared with agents such as diazepam (longer‑acting) or alprazolam (shorter‑acting). Its pharmacokinetic profile makes it suitable for acute anxiety, procedural sedation, and seizure emergencies.

Lambutrix should be stored at controlled room temperature, typically below 25 °C, in its original packaging. Protect the product from excessive light, moisture, and temperature fluctuations to maintain stability.

Lambutrix is supplied as an injectable solution for intramuscular or intravenous administration. The route, rate, and volume are determined by the healthcare professional based on the clinical indication and patient needs.

Serious risks include respiratory depression, severe hypotension, paradoxical agitation, and the potential for dependence and withdrawal symptoms if the drug is stopped abruptly after prolonged use. Immediate medical attention is required if any of these occur.

Lambutrix is contraindicated in patients with known hypersensitivity to lorazepam or other benzodiazepines, those with acute narrow‑angle glaucoma, and individuals taking potent CNS depressants where additive effects could be life‑threatening. Clinicians should evaluate each patient’s medical history before prescribing.